
Avantor (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company operates on a global scale, delivering a broad portfolio of products and services that are essential for biopharmaceutical development, healthcare research, discovery and production of new drugs, and educational laboratories. Avantor's projects range from research and development in the life sciences to providing advanced materials for various industrial applications. The company's objective is to set science in motion to create a better world, offering innovative products and services to help its customers solve complex challenges, improve patient outcomes, and enhance quality of life globally.